A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Message: AGORACOM Small Cap 60: Valeo Pharma Awarded 2 Multi-Year Listing Agreements By Two of Canada's largest Group Purchasing Organizations

AGORACOM Small Cap 60: Valeo Pharma Awarded 2 Multi-Year Listing Agreements By Two of Canada's largest Group Purchasing Organizations

posted on Oct 29, 2021 03:07PM

Share
New Message
Please login to post a reply